$0.550
+0 (+0%)
At Close: May 09, 2025
Marinus Pharmaceuticals shares are trading lower after the company announced a proposed offering of common stock.
12:18pm, Friday, 29'th May 2020Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
01:23am, Friday, 29'th May 2020
The gross proceeds of the offering to the Company are expected to be approximately $40,000,000, before deducting the underwriting discounts and commissions and other estimated offering expenses. In a
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
12:00am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 28)
ADC Therapeutics SA (NYSE:...
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock
09:01pm, Thursday, 28'th May 2020
RADNOR, May 28, 2020 (GLOBE NEWSWIRE via COMTEX) --
RADNOR, Pa., May 28, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) ("Marinus" or...
Marinus Pharmaceuticals shares are trading lower after the company announced a proposed offering of common stock.
08:13pm, Thursday, 28'th May 2020Marinus Pharmaceuticals Announces A Proposed Offering Of The Company's Common Stock
08:02pm, Thursday, 28'th May 2020Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock
08:01pm, Thursday, 28'th May 2020
All of the shares to be sold in the offering will be offered by Marinus. In addition, Marinus intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the numbe
Michael R. Dougherty Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.
12:40pm, Thursday, 28'th May 2020
BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today appointed Mr. Michael R. Dougherty to the Board of Directors of its majority-owned
Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock
12:00am, Thursday, 28'th May 20203 “Strong Buy” Penny Stocks With Triple-Digit Upside
06:22pm, Thursday, 14'th May 2020
Given the troubling state of the U.S. economy, what’s driving the bullish sentiment on Wall Street? Stimulus.Among the bulls is chief investment strategist at CFRA, Sam Stovall, who estimates that t
Epilepsy Industry Assessment 2016-2024 - ResearchAndMarkets.com
12:00am, Monday, 11'th May 2020
The
Edited Transcript of MRNS earnings conference call or presentation 4-May-20 12:30pm GMT
11:51am, Saturday, 09'th May 2020
Q1 2020 Marinus Pharmaceuticals Inc Earnings Call
Sign In
Buy MRNS